Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Current Drug Targets|August 3, 2013
The first approved agent in the Glitazar's Class: SaroglitazarRitesh AgrawalRecent Patents on Anti-Cancer Drug Discovery|May 22, 2014
Next generation tyrosine kinase inhibitor (TKI): afatinibSuresh Kumar, Ritesh AgrawalRNA (New York, N.Y.)|April 21, 2005
Editing efficiency of a Drosophila gene correlates with a distant splice site selectionRitesh Agrawal, Gary D StormoBioinformatics (Oxford, England)|April 6, 2006
Using mRNAs lengths to accurately predict the alternatively spliced gene products in Caenorhabditis elegansRitesh Agrawal, Gary D StormoRecent Patents on Endocrine, Metabolic & Immune Drug Discovery|July 1, 2014
Insulin therapy: going the "smarter" waySanjay Kalra, Ameya Joshi, Girish ParmarJPMA. the Journal of the Pakistan Medical Association|October 25, 2022
Osteoporosis and diabetes: The dual pandemicsSanjay Kalra, Ameya Joshi, Nitin KapoorJournal of the ASEAN Federation of Endocrine Societies|June 12, 2024
The Acute Coronary Syndrome Risk in Medically Managed Subjects with Type 2 Diabetes Mellitus - Is the ASCVD Risk Score Failing Here?Ameya Joshi, Harminder Singh, Sanjay KalraActa Bio-Medica : Atenei Parmensis|September 16, 2008
Duodenal adenoma presenting as duodenojejunal intussusceptionProbal Neogi, Alok Misra, Ritesh AgrawalCurrent Drug Targets|January 19, 2012
Apixaban: a new player in the anticoagulant classRitesh Agrawal, Pratima Jain, S N DikshitCombinatorial Chemistry & High Throughput Screening|November 13, 2012
Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agentsRitesh Agrawal, Pratima Jain, Subodh Narayan DikshitPageof 9